Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients.

My Cancer Genome (MCG), a web-based cancer information tool developed by Vanderbilt-Ingram Cancer Center investigators in 2011 and supported by GenomOncology, has launched a new clinical trial search tool (https://beta.mycancergenome.org) that allows website visitors to search for cancer clinical trials based on disease, biomarker, phase and recruiting status.

Visitors also can preview the new My Cancer Genome homepage at www.mycancergenome.org.

While the first version of MCG’s clinical trial search vehicle permitted searching by gene, the new version permits search by specific genetic variant or other biomarkers.

Trial documents are downloaded nightly from ClinicalTrials.gov and the National Cancer Institute (NCI) Clinical Trials Reporting Program’s list of NCI-supported clinical trials. Trials then undergo automated and manual curation to ensure the highest quality data.

Other types of data, such as trial phase and recruiting status, are structured in the trial documents and can be automatically curated for each clinical trial. The MCG search tool is designed specifically for cancer clinical trials with an interventional therapy and with biomarkers as part of eligibility requirements.

This story originally appeared on Nashville Medical News.